000 01422 a2200385 4500
005 20250518071450.0
264 0 _c20210726
008 202107s 0 0 eng d
022 _a1875-6190
024 7 _a10.2174/1570159X17666191118125018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOrekhov, Alexander N
245 0 0 _aMitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.
_h[electronic resource]
260 _bCurrent neuropharmacology
_c2020
300 _a1064-1075 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAtherosclerosis
_xmetabolism
650 0 4 _aCholesterol, LDL
650 0 4 _aDNA, Mitochondrial
650 0 4 _aHumans
650 0 4 _aInflammation
_xpathology
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aMitophagy
650 0 4 _aMuscle, Smooth, Vascular
650 0 4 _aMutation
650 0 4 _aOxidative Stress
650 0 4 _aPlaque, Atherosclerotic
700 1 _aPoznyak, Anastasia V
700 1 _aSobenin, Igor A
700 1 _aNikifirov, Nikita N
700 1 _aIvanova, Ekaterina A
773 0 _tCurrent neuropharmacology
_gvol. 18
_gno. 11
_gp. 1064-1075
856 4 0 _uhttps://doi.org/10.2174/1570159X17666191118125018
_zAvailable from publisher's website
999 _c30329882
_d30329882